Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer.
Wakabayashi Y, Masuda T, Fujitaka K, Nakashima T, Okumoto J, Shimoji K, Nishimura Y, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Ohshimo S, Hamada H, Hattori N.
Wakabayashi Y, et al. Among authors: miyamoto s.
Cancer Sci. 2021 Jan;112(1):369-379. doi: 10.1111/cas.14711. Epub 2020 Nov 12.
Cancer Sci. 2021.
PMID: 33103296
Free PMC article.